Coagulation studies: Difference between revisions

No edit summary
No edit summary
Line 1: Line 1:
*PT/INR
== Core Labs ==
*PTT
=== PT (Prothrombin Time) ===
* Measures extrinsic & common pathways (factors I, II, V, VII, X)
* Normal: 11–13.5 sec
* Prolonged in: warfarin use, liver disease, vitamin K deficiency, DIC
 
=== INR (International Normalized Ratio) ===
* Standardized PT
* Normal: 0.8–1.2
* Target therapeutic: 2–3 (DVT/PE/AF); 2.5–3.5 (mechanical valves)
* >1.5 with bleeding or planned procedure may warrant reversal
 
=== aPTT (Activated Partial Thromboplastin Time) ===
* Measures intrinsic & common pathways (factors I, II, V, VIII, IX, X, XI, XII)
* Normal: 25–35 sec
* Prolonged in: heparin, hemophilia A/B, lupus anticoagulant, DIC
 
=== Fibrinogen ===
* Acute phase reactant; substrate for clot formation
* Normal: 200–400 mg/dL
* Low in: DIC, liver disease, fibrinolysis
 
=== D-Dimer ===
* Marker of fibrin degradation
* Normal: <500 ng/mL (varies by assay/age)
* Elevated in: VTE, trauma, infection, cancer, pregnancy, DIC
 
== Red Flags in the ED ==
* Bleeding with elevated PT/INR only: Think warfarin, liver disease, vitamin K deficiency.
* Bleeding with elevated aPTT only: Think heparin, hemophilia, lupus anticoagulant.
* Both PT and aPTT elevated: Consider DIC, liver failure, anticoagulant overdose.
* Normal PT/aPTT with bleeding: Platelet dysfunction, von Willebrand disease, factor XIII deficiency.
* Elevated D-dimer: Not specific — never diagnostic, but sensitive for VTE when combined with low Wells score.
 
== Urgent Reversals ==
=== Warfarin (INR ≥3 or bleeding) ===
* Vitamin K IV + PCC (e.g., Kcentra)
* FFP if PCC unavailable
 
=== Heparin ===
* Protamine sulfate (1 mg per 100 units heparin given in last 2–3 hrs)
 
=== DOACs (apixaban, rivaroxaban) ===
* Consider andexanet alfa (if available)
* Activated charcoal if <2 hrs from ingestion
* PCC off-label if bleeding and drug unknown
 
{| class="wikitable"
|+ Key Differentials by Lab Pattern
|-
! PT !! aPTT !! Diagnosis
|-
| ↑ || Normal || Warfarin, early liver disease
|-
| Normal || ↑ || Heparin, hemophilia, lupus inhibitor
|-
| ↑ || ↑ || DIC, advanced liver disease, vitamin K deficiency
|-
| Normal || Normal || Platelet disorder, von Willebrand disease
|}
 
 
== When to Order What ==
* PT/INR: On all bleeding patients, before procedures, warfarin monitoring
* aPTT: If patient is on heparin or has unexplained bleeding
* D-dimer: Rule out VTE in low-pretest probability
* Fibrinogen/D-dimer: Suspect DIC, trauma, sepsis


[[Category:Heme/Onc]]
[[Category:Heme/Onc]]

Revision as of 16:22, 5 May 2025

Core Labs

PT (Prothrombin Time)

  • Measures extrinsic & common pathways (factors I, II, V, VII, X)
  • Normal: 11–13.5 sec
  • Prolonged in: warfarin use, liver disease, vitamin K deficiency, DIC

INR (International Normalized Ratio)

  • Standardized PT
  • Normal: 0.8–1.2
  • Target therapeutic: 2–3 (DVT/PE/AF); 2.5–3.5 (mechanical valves)
  • >1.5 with bleeding or planned procedure may warrant reversal

aPTT (Activated Partial Thromboplastin Time)

  • Measures intrinsic & common pathways (factors I, II, V, VIII, IX, X, XI, XII)
  • Normal: 25–35 sec
  • Prolonged in: heparin, hemophilia A/B, lupus anticoagulant, DIC

Fibrinogen

  • Acute phase reactant; substrate for clot formation
  • Normal: 200–400 mg/dL
  • Low in: DIC, liver disease, fibrinolysis

D-Dimer

  • Marker of fibrin degradation
  • Normal: <500 ng/mL (varies by assay/age)
  • Elevated in: VTE, trauma, infection, cancer, pregnancy, DIC

Red Flags in the ED

  • Bleeding with elevated PT/INR only: Think warfarin, liver disease, vitamin K deficiency.
  • Bleeding with elevated aPTT only: Think heparin, hemophilia, lupus anticoagulant.
  • Both PT and aPTT elevated: Consider DIC, liver failure, anticoagulant overdose.
  • Normal PT/aPTT with bleeding: Platelet dysfunction, von Willebrand disease, factor XIII deficiency.
  • Elevated D-dimer: Not specific — never diagnostic, but sensitive for VTE when combined with low Wells score.

Urgent Reversals

Warfarin (INR ≥3 or bleeding)

  • Vitamin K IV + PCC (e.g., Kcentra)
  • FFP if PCC unavailable

Heparin

  • Protamine sulfate (1 mg per 100 units heparin given in last 2–3 hrs)

DOACs (apixaban, rivaroxaban)

  • Consider andexanet alfa (if available)
  • Activated charcoal if <2 hrs from ingestion
  • PCC off-label if bleeding and drug unknown
Key Differentials by Lab Pattern
PT aPTT Diagnosis
Normal Warfarin, early liver disease
Normal Heparin, hemophilia, lupus inhibitor
DIC, advanced liver disease, vitamin K deficiency
Normal Normal Platelet disorder, von Willebrand disease


When to Order What

  • PT/INR: On all bleeding patients, before procedures, warfarin monitoring
  • aPTT: If patient is on heparin or has unexplained bleeding
  • D-dimer: Rule out VTE in low-pretest probability
  • Fibrinogen/D-dimer: Suspect DIC, trauma, sepsis